Financials

  • Market Capitalization 338.76 M
  • Employee 87
  • Founded N/A
  • CEO N/A
  • Website www.editasmedicine.com
  • Headquarter Delaware, United States
  • FIGI BBG005MX5GZ2
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-2.17
Índice preço/fluxo de caixa
5.69

Editas Medicine, Inc. - Common Stock

Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

Notícias